Vanda Pharmaceuticals Cash Conversion Cycle 2011-2026 | VNDA

Annual Cash Conversion Cycle Vanda Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
136	124	95.6	64	58.9	60.4	59.4	72.1	-360	-177	-171	968	-	-635	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
968	-635	22.8

Quarterly Cash Conversion Cycle Vanda Pharmaceuticals

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
146	131	-	136	-	-	-	105	86.1	64.3	-	32	31.3	66.4	-	64.3	62.9	64.8	40.5	65.2	64	65.6	39.5	55.8	57.1	71.8	49.5	53.5	55.5	48.5	36.3	38.9	38.2	46.2	48.4	48.1	51.3	50.2	46.8	52.6	54	41.2	21.7	22.6	30.7	28.4	21.1	21.3	22.3	18.1	13.5	12.9	12.7	15.6	17.6	18.5	19.9	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
146	12.7	49.1

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
AbCellera Biologics ABCL	173	$ 3.74	3.6 %	$ 1.12 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-8.96 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	-6 K	$ 3.36	0.86 %	$ 1.2 M	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Agios Pharmaceuticals AGIO	735	$ 29.16	-3.54 %	$ 1.69 B	USA
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Завод ДИОД DIOD	-32.7	-	-	-	Russia
Фармсинтез LIFE	-15.9	-	-	-	Russia
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Alector ALEC	-13.8	$ 2.19	-9.77 %	$ 226 M	USA
Altimmune ALT	15.1 K	$ 4.21	-2.32 %	$ 299 M	USA
Teligent, Inc. TLGT	120	-	-13.85 %	$ 16.1 M	USA
Evogene Ltd. EVGN	-32.5	$ 0.84	-4.24 %	$ 27.9 M	Israel
Viela Bio, Inc. VIE	139	-	-	$ 2.91 B	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Amarin Corporation plc AMRN	157	$ 13.98	1.27 %	$ 5.7 B	Irlanda
AbbVie ABBV	284	$ 233.57	0.64 %	$ 413 B	USA
Blueprint Medicines Corporation BPMC	254	-	-	$ 8.14 B	USA
AIM ImmunoTech AIM	46	$ 0.8	-11.6 %	$ 38.5 M	USA
Aptorum Group Limited APM	-400	$ 0.83	5.37 %	$ 4.53 M	China
Apellis Pharmaceuticals APLS	115	$ 20.67	-1.38 %	$ 2.61 B	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Cleveland BioLabs, Inc. CBLI	128	-	-7.31 %	$ 49 M	USA